ARCHIVES

Novel Four Drug Combination Safe For Lung Cancer Therapy

This article is from The Cancer Letter archive.

Vol. 31 No. 11 | November 28, 2008

Download PDF Visit The Full Archive

Related Articles

Roger Bonus Bill Wouldn’t Keep Rauscher

May 28, 1976

NCI Awards Regional CIS Contracts

August 6, 1993

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011

Breast Cancer action Plan Calls For More federal Coordination, Patient Participation

March 23, 1994

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

November 16, 2012

In Brief: NCI Thinks Puerto Rico Should Have Comprehensive Center; President Says He Won’t Oppose NIH Budget Increases

April 26, 1974